Chronic Toxicity After Adjuvant Anti-PD-1 in Melanoma Under Scrutiny
Melanoma survivors treated with adjuvant anti-PD-1 face persistent immune-related toxicities; Andrea Boutros examines the long-term burden in Oncodaily.
Topic
Immune Related Adverse Events
Topic
Immune Related Adverse Events
Necrotic Eruptions Flag Severe ICI-Associated Myositis in JAAD Report
Dermatologists should treat necrotic skin eruptions in cancer patients on immune checkpoint inhibitors as a red flag for severe m…
Expert Consensus Maps Diagnosis, Treatment of Immunotherapy Skin Rashes
A new expert consensus lays out a structured framework for diagnosing and treating skin rashes in patients receiving cancer immun…